Literature DB >> 25381767

Manipulated microenvironment in human papilloma virus-infected epithelial cells: is the CD40-CD154 pathway beneficial for host or virus?

Takatoshi Shimauchi1, Vincent Piguet2.   

Abstract

In this issue, Tummers et al. (2014) demonstrate that high-risk human papilloma viruses (hrHPVs) attenuate the magnitude of responses to CD40 ligation and the epithelial cells' (ECs) capacity to attract leukocytes. These results suggest that hrHPVs can escape from host immune surveillance by modulating pro-inflammatory responses in infected ECs, resulting in persistent infections and potential carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25381767     DOI: 10.1038/jid.2014.357

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.

Authors:  Soo-Jong Um; Jae-Woong Rhyu; Eun-Joo Kim; Kook-Che Jeon; Eun-Seoung Hwang; Jong-Sup Park
Journal:  Cancer Lett       Date:  2002-05-28       Impact factor: 8.679

2.  Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.

Authors:  Maria C Lebre; Angelic M G van der Aar; Lisa van Baarsen; Toni M M van Capel; Joost H N Schuitemaker; Martien L Kapsenberg; Esther C de Jong
Journal:  J Invest Dermatol       Date:  2006-10-26       Impact factor: 8.551

3.  CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.

Authors:  A Altenburg; S E Baldus; H Smola; H Pfister; S Hess
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density.

Authors:  Qin Huang; Qiu-Xia Qu; Fang Xie; Ting Zhang; Jian-Ming Hu; You-Guo Chen; Xue-Guang Zhang
Journal:  Cancer Epidemiol       Date:  2011-01-19       Impact factor: 2.984

5.  The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

Authors:  S Li; S Labrecque; M C Gauzzi; A R Cuddihy; A H Wong; S Pellegrini; G J Matlashewski; A E Koromilas
Journal:  Oncogene       Date:  1999-10-14       Impact factor: 9.867

Review 6.  Epithelial cells as immune effector cells: the role of CD40.

Authors:  Kari Dugger; Thomas W Lowder; Torry A Tucker; Lisa M Schwiebert
Journal:  Semin Immunol       Date:  2009-07-22       Impact factor: 11.130

7.  Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.

Authors:  Rezaul Karim; Craig Meyers; Claude Backendorf; Kristina Ludigs; Rienk Offringa; Gert-Jan B van Ommen; Cornelis J M Melief; Sjoerd H van der Burg; Judith M Boer
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

8.  Giving blood: a new role for CD40 in tumorigenesis.

Authors:  Stephan Bergmann; Pier Paolo Pandolfi
Journal:  J Exp Med       Date:  2006-10-16       Impact factor: 14.307

9.  Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response.

Authors:  Rezaul Karim; Bart Tummers; Craig Meyers; Jennifer L Biryukov; Samina Alam; Claude Backendorf; Veena Jha; Rienk Offringa; Gert-Jan B van Ommen; Cornelis J M Melief; Daniele Guardavaccaro; Judith M Boer; Sjoerd H van der Burg
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

Review 10.  Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.

Authors:  Alfredo Amador-Molina; José Fernando Hernández-Valencia; Edmundo Lamoyi; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2013-10-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.